Collard Craig A sold HRTX
January 19, 2024 · Form 4 insider transaction
Collard Craig A sold 13,797 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 91 days after the transaction.
Direction
Disposed (sell-side)
Shares
13,797
Price
$0.00
Total value
N/A
InsiderCollard Craig A
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeM: Option exercise
Transaction dateJanuary 19, 2024
Filing dateApril 19, 2024
Shares owned after206,953
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).